In-vessel implantable smart sensing device for personalised medicine
The IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations.
Projectdetails
Introduction
The IV-Lab project aims at designing and manufacturing a miniaturized sensing device implantable in the blood vessel for monitoring the health status of patients. The micro-sensor system would implement a body-embedded system with multiple sensing capabilities, targeting hemodynamic and biochemical parameters, once implanted into blood vessels (vein and/or arterial blood vessels) of vulnerable patients with cardiovascular diseases.
Objectives
The final goal of the proposal aims at responding to the main requests from the Pathfinder Health work program, which is to endow people with unperceivable sensors. This will allow:
- The continuous long-term monitoring of the health status.
- The diagnosis and personalized medical intervention.
Functionality
Once in the vessel, the sensor will be completely unobtrusive and capable of continuous monitoring. The implanted system will be connected with (and powered by) an external data collection and communication system coupled through standardized wireless technology (i.e., NFC), or even simply by a smartphone in case of asynchronous on-demand monitoring.
Design
The device will have a miniaturized shape and size, allowing placement inside veins and arteries without impairing blood flow. It will be provided with multiple different sensors, able to work in a continuous or asynchronous way, depending on the specific use cases.
Applications
This device will find important applications in the field of cardiovascular disease, particularly in patients where the detection of hemodynamic behavior and specific biomarkers could reduce re-hospitalization and mortality (i.e., heart failure).
Future Perspectives
Moreover, in perspective, the system will make it possible to monitor the development and outcome of different diseases, allowing for prompt and tailored treatment.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 4.158.610 |
Totale projectbegroting | € 4.158.610 |
Tijdlijn
Startdatum | 1-9-2023 |
Einddatum | 31-8-2027 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIApenvoerder
- CONSIGLIO NAZIONALE DELLE RICERCHE
- THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
- FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
- UNIVERSITY OF STUTTGART
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Mid-infrared Wearable for Non-invasive biomarker monitoringThe project aims to develop a wearable device using a miniature Mid-Infrared spectrometer for non-invasive biomarker detection in metabolic syndrome, enhancing early diagnosis and management. | EIC Pathfinder | € 3.991.297 | 2024 | Details |
Speckle Technology and Digital Biomarkers of Microvascular Function for Monitoring Cardiovascular DiseasesThe project aims to develop innovative monitoring instruments for early detection of cardiovascular diseases, integrating advanced technologies to reduce healthcare burdens and costs in the EU. | EIC Pathfinder | € 3.979.006 | 2023 | Details |
Blood as energy source to power smart cardiac devicesThe BLOOD2POWER project aims to develop energy-harvesting vascular grafts using triboelectric nanogenerators to monitor performance and prevent failure through wireless data transmission. | EIC Pathfinder | € 2.885.525 | 2023 | Details |
Unobtrusive Continuous Multi-Metabolite Monitoring for a Physiological Care of Insulin-treated DiabetesThis project aims to revolutionize diabetes management through a fully implantable multi-metabolite monitoring system and automated insulin delivery, enhancing metabolic health and reducing complications. | EIC Pathfinder | € 3.885.462 | 2023 | Details |
Mid-infrared Wearable for Non-invasive biomarker monitoring
The project aims to develop a wearable device using a miniature Mid-Infrared spectrometer for non-invasive biomarker detection in metabolic syndrome, enhancing early diagnosis and management.
Speckle Technology and Digital Biomarkers of Microvascular Function for Monitoring Cardiovascular Diseases
The project aims to develop innovative monitoring instruments for early detection of cardiovascular diseases, integrating advanced technologies to reduce healthcare burdens and costs in the EU.
Blood as energy source to power smart cardiac devices
The BLOOD2POWER project aims to develop energy-harvesting vascular grafts using triboelectric nanogenerators to monitor performance and prevent failure through wireless data transmission.
Unobtrusive Continuous Multi-Metabolite Monitoring for a Physiological Care of Insulin-treated Diabetes
This project aims to revolutionize diabetes management through a fully implantable multi-metabolite monitoring system and automated insulin delivery, enhancing metabolic health and reducing complications.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
SmartIVHet project onderzoekt de haalbaarheid van een bio-geïnspireerd inline infuusmonitoringsysteem om de veiligheid van IV-infusen te verbeteren door nauwkeurige flowmeting en commerciële strategieën te evalueren. | Mkb-innovati... | € 19.983 | 2022 | Details |
Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosisVesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Implantable sensors and ultrasonic data link with triggered bioresorption for next-gen wireless cardiac monitoringThe 2ND-CHANCE project aims to develop bioresorbable implants for continuous cardiac monitoring post-surgery, reducing rehospitalization risks and eliminating the need for removal surgery. | ERC Starting... | € 2.500.000 | 2022 | Details |
Novel microsensing platform for remote patient monitoringThe FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users. | EIC Transition | € 2.499.051 | 2023 | Details |
Geautomatiseerde bloeddrukmetingHet project onderzoekt de haalbaarheid van continue bloeddrukmeting met innovatieve technologieën voor betere cardiovasculaire zorg. | Mkb-innovati... | € 20.000 | 2022 | Details |
SmartIV
Het project onderzoekt de haalbaarheid van een bio-geïnspireerd inline infuusmonitoringsysteem om de veiligheid van IV-infusen te verbeteren door nauwkeurige flowmeting en commerciële strategieën te evalueren.
Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosis
VesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs.
Implantable sensors and ultrasonic data link with triggered bioresorption for next-gen wireless cardiac monitoring
The 2ND-CHANCE project aims to develop bioresorbable implants for continuous cardiac monitoring post-surgery, reducing rehospitalization risks and eliminating the need for removal surgery.
Novel microsensing platform for remote patient monitoring
The FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users.
Geautomatiseerde bloeddrukmeting
Het project onderzoekt de haalbaarheid van continue bloeddrukmeting met innovatieve technologieën voor betere cardiovasculaire zorg.